Alpha DNA Investment Management’s Chubb CB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,679
Closed -$2.12M 38
2024
Q4
$2.12M Sell
7,679
-228
-3% -$64.7K 0.81% 20
2024
Q3
$2.28M Sell
7,907
-210
-3% -$57.6K 0.85% 14
2024
Q2
$2.07M Sell
8,117
-8,437
-51% -$2.17M 0.8% 21
2024
Q1
$4.29M Buy
16,554
+3,721
+29% +$915K 1.58% 5
2023
Q4
$2.9M Buy
12,833
+1,997
+18% +$437K 1.13% 11
2023
Q3
$2.26M Sell
10,836
-21
-0.2% -$4.25K 0.92% 12
2023
Q2
$2.09M Buy
10,857
+839
+8% +$164K 0.7% 22
2023
Q1
$1.95M Buy
10,018
+1,194
+14% +$251K 0.57% 20
2022
Q4
$1.95M Buy
8,824
+2,500
+40% +$520K 0.69% 13
2022
Q3
$1.15M Buy
+6,324
New +$1.2M 0.96% 28
2021
Q2
Sell
-317
Closed -$49K 179
2021
Q1
$49K Hold
317
0.06% 176
2020
Q4
$48K Buy
+317
New +$44.4K 0.05% 184

Other funds holding CB

Alpha DNA Investment Management's CB Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Chubb (CB) in Q1 2025, closing a stake of 7,679 shares — an estimated $2.12M sold.

Alpha DNA Investment Management first reported a position in CB in Q4 2020 and held it in 12 quarters. The position peaked at $4.29M in Q1 2024. 1,916 funds tracked by Wall St. Rank hold CB as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Chubb position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 7,679 Chubb shares in Q1 2025, an estimated $2.12M.
  • Alpha DNA Investment Management first reported a position in Chubb in Q4 2020 and held it in 12 quarters.
  • Alpha DNA Investment Management's Chubb position peaked at $4.29M in Q1 2024.
  • 1,916 funds tracked by Wall St. Rank held Chubb as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.